MktsMarkets

InMed Pharmaceuticals Inc.
NASDAQ: INMKey statistics
INM News
Stories mentioning INM from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 820.00 | 1,120 | 1,304 | 1,262 | 1,112 | 1,265 | 1,283 | |
| Cost of Goods Sold | 636.00 | 717.00 | 728.00 | 1,086 | 651.00 | 771.00 | 817.00 | |
| Gross Profit | 0.00 | 184.00 | 403.00 | 577.00 | 176.00 | 461.00 | 493.00 | 467.00 |
| Operating Expenses | ||||||||
| Research & Development | 1,023 | 631.00 | 582.00 | 834.00 | 425.00 | 895.00 | 700.00 | 659.00 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 2,840 | 2,287 | 2,224 | 2,626 | 2,084 | 2,715 | 2,228 | 2,500 |
| Operating Income (Loss) | ||||||||
| Interest Income | 48.00 | 74.00 | 94.00 | 51.00 | 17.00 | 31.00 | 57.00 | 104.00 |
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (2,792) | (2,028) | (1,727) | (1,842) | (2,067) | (2,575) | (1,678) | (1,930) |
| Tax Provision | ||||||||
| Net Income (Loss) | (2,966) | (2,028) | (1,727) | (1,788) | (2,121) | (2,575) | (1,678) | (1,938) |
| Earnings Per Share (Basic) | (0.73) | (0.51) | (0.44) | (1.83) | (1.94) | (3.64) | (2.71) | (5.09) |
| Earnings Per Share (Diluted) | (0.73) | (0.51) | (0.44) | (1.83) | (1.94) | (3.64) | (2.71) | (5.09) |
| Weighted Average Shares Outstanding (Basic) | 4,048 | 3,955 | 3,955 | 976.00 | 1,096 | 707.00 | 620.00 | 381.00 |
| Weighted Average Shares Outstanding (Diluted) | 4,048 | 3,955 | 3,955 | 976.00 | 1,096 | 707.00 | 620.00 | 381.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About INM
InMed Pharmaceuticals Inc. (NASDAQ: INM) is a stock listed on the Nasdaq Stock Market under the ticker symbol INM. It last traded at $14.70 (Nov 19, 2026, 7:00 PM ET), down 3.5% on the day. That gives InMed Pharmaceuticals a market capitalisation of $9.6M.
Over the past 52 weeks INM has traded between $5.75 and $23.30.
For the quarter ended Mar 31, 2026 it reported a net loss of $3.0M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | — | -$3.0M | — |
| Dec 31, 2025 | $820.0K | -$2.0M | -247.3% |
| Sep 30, 2025 | $1.1M | -$1.7M | -154.2% |
| Jun 30, 2025 | $1.3M | -$1.8M | -137.1% |
From InMed Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…